- 02:52 AM Mahindra arm to bid for USD 3.5bn defence deals
- 09:30 PM Positive global cues, RIL power markets
- 09:19 PM Hindalco launches $600m QIP book at Rs 130.9/s...
- 09:00 PM After per second billing, what next for telecom?
- 08:53 PM Prestige Group ramps up investment plans
- 08:35 PM Property prices likely to go up in December
- 07:55 PM Mahindra arm to bid for $3.5 bn defence deals
- 07:26 PM Tech Toyz celebrates the waning of recession
- 07:23 PM Experts see mkts at new highs, advise sectors
- 07:21 PM HCL Tech bags $200m order from UK’s Equitable ...
Aurobindo Pharma Limited is pleased to announce that the company has received one more approval from the US FDA for Amoxicillin Tablets For oral suspension 200mg and 400mg.
Amoxicillin Tablets for oral suspension is a Beta-lactam antibiotic used often in treating respiratory infections. With this approval Aurobindo has its Amoxicillin approved by USFDA in four different formulations.
Sourced From: Aurobindo Pharma Limited
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- Experts see mkts at new highs, advise sectors
- Corrections in '10 to be more aggressive, violent: JPMorgan
- Bollywood actress Shilpa Shetty marries Raj Kundra
- Mahindra arm to bid for $3.5 bn defence deals
- 10 companies that MF managers love
- Trading in MF units to start in 15 days: SEBI
- Ignore Buffett, gold`s time has come
- Positive global cues, RIL power markets
Source: CNBC-TV18
- Hindalco launches $600m QIP book at Rs 130.9/sh
Source: CNBC-TV18
- After per second billing, what next for telecom?
Source: CNBC-TV18
- Prestige Group ramps up investment plans
Source: CNBC-TV18
- China`s Haitong Securities buys Hong Kong rival
Source: ft.com
- KSIDC in pact with FACT for trade centre
Source: Business Line
- GIC Re may have to pay Rs100cr for IOC's Jaipur fire claims
Source: Business Line
- Co-operative dairies seek restraint on oil-meal exports
Source: Business Line
